COMMUNIQUÉS West-GlobeNewswire

Nicox Announces Improved Financial Terms from Bausch + Lomb for VYZULTA

14/03/2018 - 07:31

Press Release Nicox Announces Improved Financial Terms from Bausch + Lomb for VYZULTA TM Increase in Royalties by 1% on Annual VYZULTA TM Global Sales Revenue Over $300 Million Additional $20 Million in Potential [...]

2017: Tecan with significant increase in sales and profit

14/03/2018 - 06:31

Financial results: full-year and second half of 2017 Order entry of CHF 564.1 million (2016: CHF 503.2 million) Full-year growth of 11.8% in local currencies or 12.1% in Swiss francs Double-digit growth rates in both [...]

Immuron Announces A$5.1M Private Placement to U.S. Fund

13/03/2018 - 23:20

MELBOURNE, Australia, March 13, 2018 (GLOBE NEWSWIRE) -- Immuron Limited (ASX:IMC) (NASDAQ: IMRN ), an Australian microbiome biopharmaceutical company focused on developing and commercializing orally delivered targeted [...]

BioStem Technologies Inc. Announces Engagement of Dr. Felix Amon for Pharmaceutical Business Development

13/03/2018 - 23:16

Pompano Beach, FL, March 13, 2018 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM) (“BioStem” or the “Company”), a global life sciences corporation, providing innovative technologies with a focus in [...]

CORRECTING and REPLACING -- Intercept to Present at Upcoming Conference

13/03/2018 - 22:48

NEW YORK, March 13, 2018 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT ) please note that the conference date should be March 20, not [...]

Antares Pharma Provides Update Regarding the Cowen and Company 38th Annual Healthcare Conference

13/03/2018 - 22:45

EWING, N.J., March 13, 2018 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS ) (the Company) today announced that due to the blizzard conditions and lack of travel options present in the greater Boston area, the [...]

Xeris Pharmaceuticals Announces a Formulation Development Collaboration with Asahi Kasei Pharma

13/03/2018 - 22:00

Chicago, March 13, 2018 (GLOBE NEWSWIRE) -- Xeris Pharmaceuticals, Inc. (“Xeris”), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable and [...]

Vericel to Present at the 17th Annual Needham Healthcare Conference

13/03/2018 - 22:00

CAMBRIDGE, Mass., March 13, 2018 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ: VCEL ), a leader in advanced cell therapies for the sports medicine and severe burn care markets, today announced that Nick Colangelo, [...]

Intercept to Present at Upcoming Conference

13/03/2018 - 22:00

NEW YORK, March 13, 2018 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT ), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non- [...]

Sienna Senior Living Inc. Added to S&P/TSX Composite Index

13/03/2018 - 21:40

MARKHAM, Ontario, March 13, 2018 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“ Sienna ” or the “ Company ”) (TSX: SIA ) is pleased to announce that it will be added to the S&P/TSX Composite Index effective March [...]

Rockwell Medical, Inc. Appoints Two Independent and Experienced Life Sciences Executives to Board of Directors

13/03/2018 - 21:35

Lisa Colleran and Benjamin Wolin Unanimously Appointed to Rockwell Board Wolin Named Chairman of the Board Company Reaches Support Agreement with Richmond Brothers WIXOM, Mich., March 13, 2018 (GLOBE NEWSWIRE) -- [...]

Melinta Therapeutics Cancels Presentation at The Cowen & Company 38th Annual Health Care Conference Due to Inclement Weather

13/03/2018 - 21:35

NEW HAVEN, Conn., March 13, 2018 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT ), a commercial-stage company developing and commercializing novel antibiotics to treat serious bacterial infections, [...]

ERYTECH to Webcast Presentation at the Cowen and Company 38th Annual Healthcare Conference

13/03/2018 - 21:30

ERYTECH to Webcast Presentation at the Cowen and Company 38 th Annual Healthcare Conference Lyon (France), March 13, 2018 - ERYTECH Pharma (Euronext Paris: ERYP - Nasdaq: ERYP), a clinical-stage biopharmaceutical [...]

Dyadic International to Announce Year End 2017 Financial Results and Host Conference Call on Tuesday March 27, 2018

13/03/2018 - 21:30

JUPITER, Fla., March 13, 2018 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”) (OTCQX:DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 expression system to help [...]

Teligent, Inc. to Present at the Oppenheimer 28th Annual Healthcare Conference on Tuesday March 20, 2018

13/03/2018 - 21:30

BUENA, N.J., March 13, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT ), a New Jersey based specialty generic pharmaceutical company, will be presenting at the Oppenheimer 28 th Annual Healthcare Conference. The [...]

Auris Medical Provides Business Update

13/03/2018 - 21:15

Zug, Switzerland, March 13, 2018 - Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology, today provided an [...]

SELLAS Life Sciences to Present at the Oppenheimer 28th Annual Healthcare Conference

13/03/2018 - 21:15

NEW YORK, March 13, 2018 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group Inc., (Nasdaq: SLS ) (SELLAS), a clinical-stage biopharmaceutical company focused on novel cancer immunotherapies for a broad range of cancer [...]

Coherus BioSciences Announces New Employment Inducement Grants

13/03/2018 - 21:15

REDWOOD CITY, Calif., March 13, 2018 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq: CHRS ), today announced that effective March 12, 2018, the compensation committee of the company’s board of directors granted 2 [...]

Dr. Ernesto Aycardi Joins Xenon Pharmaceuticals as Chief Medical Officer

13/03/2018 - 21:05

BURNABY, British Columbia, March 13, 2018 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE ), a clinical stage biopharmaceutical company, today announced that Dr. Ernesto Aycardi will join the company as its [...]